This past September 25-28, 2023, over 1,100 international attendees (90% in-person) learned and networked together at our 20th Anniversary Discovery on Target.
The sold-out Exhibit Hall featured 93 companies with novel solutions and technologies. These leading providers extended their impact across agenda presentations highlighting new offerings to the scientific community. Attendees also enjoyed 100+ posters by students, academia, and industry revealing drug discovery research on the cutting edge.
The event included 275+ expert speakers, 16 conference tracks, 2 symposia, 8 interactive courses, and 1 in-depth training seminar. Interest and track hopping were healthy across topics, from popular kinases and immunomodulation to protein degradation and AI; new or expanded programming on transcription factors and small molecules for cancer targets; stalwarts like antibodies; and plenty more.
For a review of fragment-based drug discovery talks written by
Dr. Daniel A. Erlanson of Frontier Medicines, click here for his Practical Fragments blogpost:
Thank you for contributing to the life science and lifeblood of Discovery on Target, via your diverse perspectives and targets. Feel free to share ideas and topics with me and submit a speaker proposal for 2024. Our team looks forward to welcoming you back to Boston for our 22nd Annual event this
September 30 - October 3, 2024. See you next fall!
Team Lead, Discovery on Target
Read attendee, sponsor and speaker testimonials here!